Molecular basis of human CD22 function and therapeutic targeting

The B-cell-specific co-receptor CD22 is a therapeutic target for depleting dysregulated B cells. Here the authors structurally characterize the ectodomain of CD22 and present its crystal structure with the bound therapeutic antibody epratuzumab, which gives insights into the mechanism of inhibition...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: June Ereño-Orbea, Taylor Sicard, Hong Cui, Mohammad T. Mazhab-Jafari, Samir Benlekbir, Alba Guarné, John L. Rubinstein, Jean-Philippe Julien
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
Q
Accès en ligne:https://doaj.org/article/04e84326931749769862d90cdc858a46
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!